At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase I Feasibility Trial of Preoperative Adjuvant Stereotactic Body Radiotherapy for Patients at High Risk of Local Failure After Prostatectomy
In Brief
A clinical study evaluating Laboratory Biomarker Analysis, Quality-of-Life Assessment, and 1 other intervention for Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7 and 2 related conditions. Completed, enrolled 11 participants across 1 site.
Detailed Summary
This phase I trial studies stereotactic body radiation therapy (SBRT) in treating patients with prostate cancer that is likely to come back or spread (high-risk) undergoing surgery. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Delivering radiotherapy before prostatectomy by SBRT is more convenient, conformal, and may spare normal tissues better than delivering radiotherapy after prostatectomy.
Study Details
Timeline
Interventions
Correlative studies
Ancillary studies
Undergo SBRT